Symbols / ABP
ABP Chart
About
Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.42M |
| Enterprise Value | 1.79M | Income | -22.04M | Sales | — |
| Book/sh | -6.04 | Cash/sh | 0.12 | Dividend Yield | — |
| Payout | 0.00% | Employees | 6 | IPO | Mar 09, 2022 |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | inf | P/B | — | P/C | — |
| EV/EBITDA | -0.19 | EV/Sales | — | Quick Ratio | 0.04 |
| Current Ratio | 0.07 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -8.25 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-14 16:00 | ROA | -229.57% |
| ROE | — | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 2.72M |
| Shs Float | 1.73M | Short Float | 1.05% | Short Ratio | 0.58 |
| Short Interest | — | 52W High | 18.03 | 52W Low | 0.11 |
| Beta | -0.00 | Avg Volume | 1.72M | Volume | 1.33M |
| Target Price | — | Recom | None | Prev Close | $0.52 |
| Price | $0.52 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.52
Latest analyst target
3. DCF / Fair value
$42.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.52
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-10-21 | down | Maxim Group | Buy → Hold | — |
| 2025-02-24 | init | Maxim Group | — → Buy | $4 |
News
RSS: Latest ABP news- Assessing Nordea Bank Abp’s Valuation After Recent Share Price Weakness - Yahoo Finance Wed, 04 Mar 2026 04
- Abpro Holdings to be delisted from Nasdaq after failing equity requirement - Investing.com Fri, 20 Feb 2026 08
- Is Nordea Bank Abp (HLSE:NDA FI) Attractive After Recent Share Price Pullback - simplywall.st Sat, 07 Mar 2026 04
- Botox biosimilar study from AEON Biopharma set for big U.S. neurology meeting - Stock Titan hu, 05 Mar 2026 21
- This Is Why Abpro Stock (ABP) Surged Today - TipRanks ue, 10 Feb 2026 08
- NORDEA BANK ABP: CANCELLATION OF SHARES - TradingView Wed, 25 Feb 2026 08
- Europe’s largest pension fund ABP divests Caterpillar shares - Pensions & Investments Wed, 01 Oct 2025 07
- IndiGo Shares Tumble Today As West Asia Crisis And Oil Rally Hit Aviation Sector - ABP Live English Mon, 09 Mar 2026 08
- Abpro Holdings stock jumps premarket after Goldman Sachs reveals 6.8% stake - TechStock² ue, 10 Feb 2026 08
- Abpro Holdings Appeals Nasdaq Delisting Notice - The Globe and Mail Sat, 04 Oct 2025 07
- Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025 - GlobeNewswire Mon, 03 Nov 2025 08
- Assessing Whether Wärtsilä Oyj Abp (HLSE:WRT1V) Is Overvalued After Its Strong Share Price Momentum - Yahoo Finance Wed, 18 Feb 2026 08
- Nordea Bank Abp - cancellation of shares - TradingView Wed, 25 Feb 2026 08
- New HER2 T-cell drug ABP-102 moves toward global trial after FDA nod - Stock Titan hu, 15 Jan 2026 08
- Abpro Holdings Faces Nasdaq Delisting, Plans Appeal - TipRanks Fri, 20 Feb 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 72035 | 20170.0 | — | Purchase at price 0.28 per share. | SUK JIN WOOK | Chief Executive Officer | — | 2025-07-31 00:00:00 | D |
| 1 | 500000 | nan | — | — | SUK JIN WOOK | Chief Executive Officer | — | 2025-07-25 00:00:00 | D |
| 2 | 16200 | 4212.0 | — | Purchase at price 0.26 per share. | SUK JIN WOOK | Chief Executive Officer | — | 2025-05-19 00:00:00 | D |
| 3 | 4325 | 1081.0 | — | Purchase at price 0.25 per share. | SUK JIN WOOK | Chief Executive Officer | — | 2025-04-29 00:00:00 | D |
| 4 | 34002 | 11113.0 | — | Purchase at price 0.28 - 0.34 per share. | SUK JIN WOOK | Chief Executive Officer | — | 2025-04-24 00:00:00 | D |
| 5 | 8652800 | — | — | Stock Award(Grant) at price 0.00 per share. | CHAN IAN | Chief Executive Officer | — | 2024-11-13 00:00:00 | D/I |
| 6 | 91900 | — | — | Stock Award(Grant) at price 0.00 per share. | SUK JIN WOOK | Chief Executive Officer | — | 2024-11-13 00:00:00 | D |
| 7 | 91900 | — | — | Stock Award(Grant) at price 0.00 per share. | SUK JIN WOOK | Chief Executive Officer | — | 2024-11-13 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.21 |
| NormalizedEBITDA | -5.73M | -10.89M | -15.78M |
| TotalUnusualItems | -489.00K | 0.00 | |
| TotalUnusualItemsExcludingGoodwill | -489.00K | 0.00 | |
| NetIncomeFromContinuingOperationNetMinorityInterest | -7.23M | -11.71M | -17.21M |
| ReconciledDepreciation | 622.00K | 792.00K | 856.00K |
| EBITDA | -6.22M | -10.89M | -15.78M |
| EBIT | -6.84M | -11.68M | -16.64M |
| NetInterestIncome | -378.00K | 40.00K | -200.00K |
| InterestExpense | 387.00K | 23.00K | 248.00K |
| InterestIncome | 9.00K | 63.00K | 48.00K |
| NormalizedIncome | -6.74M | -11.71M | -17.21M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -7.23M | -11.71M | -17.21M |
| TotalExpenses | 10.10M | 11.87M | 18.71M |
| TotalOperatingIncomeAsReported | -9.92M | -11.75M | -16.68M |
| DilutedAverageShares | 23.41M | 1.68M | 1.68M |
| BasicAverageShares | 23.41M | 1.68M | 1.68M |
| DilutedEPS | -0.74 | -6.95 | -10.22 |
| BasicEPS | -0.74 | -6.95 | -10.22 |
| DilutedNIAvailtoComStockholders | -17.41M | -11.71M | -17.21M |
| NetIncomeCommonStockholders | -17.41M | -11.71M | -17.21M |
| OtherunderPreferredStockDividend | 10.18M | 0.00 | |
| NetIncome | -7.23M | -11.71M | -17.21M |
| NetIncomeIncludingNoncontrollingInterests | -7.23M | -11.71M | -17.21M |
| NetIncomeContinuousOperations | -7.23M | -11.71M | -17.21M |
| TaxProvision | 0.00 | 330.00K | |
| PretaxIncome | -7.23M | -11.71M | -16.89M |
| OtherIncomeExpense | 3.07M | ||
| OtherNonOperatingIncomeExpenses | 3.56M | ||
| SpecialIncomeCharges | 173.00K | 0.00 | |
| OtherSpecialCharges | -173.00K | ||
| GainOnSaleOfSecurity | -662.00K | ||
| NetNonOperatingInterestIncomeExpense | -378.00K | 40.00K | -200.00K |
| InterestExpenseNonOperating | 387.00K | 23.00K | 248.00K |
| InterestIncomeNonOperating | 9.00K | 63.00K | 48.00K |
| OperatingIncome | -9.92M | -11.75M | -16.68M |
| OperatingExpense | 10.10M | 11.87M | 18.71M |
| ResearchAndDevelopment | 2.98M | 4.27M | 9.75M |
| SellingGeneralAndAdministration | 7.12M | 7.60M | 8.96M |
| GeneralAndAdministrativeExpense | 7.12M | 7.60M | 8.96M |
| OtherGandA | 7.12M | 7.60M | 8.96M |
| TotalRevenue | 183.00K | 122.00K | 2.03M |
| OperatingRevenue | 183.00K | 122.00K | 2.03M |
| Line Item | 2024-12-31 | ||
|---|---|---|---|
| TreasurySharesNumber | 983.33K | ||
| OrdinarySharesNumber | 50.83M | 50.54M | 50.54M |
| ShareIssued | 51.82M | 50.54M | 50.54M |
| NetDebt | 22.00K | 1.02M | |
| TotalDebt | 3.33M | 2.89M | 1.87M |
| TangibleBookValue | -15.67M | -89.17M | -76.48M |
| InvestedCapital | -12.62M | -87.24M | -76.28M |
| WorkingCapital | -15.83M | -13.70M | -1.22M |
| NetTangibleAssets | -15.67M | -89.17M | -76.48M |
| CapitalLeaseObligations | 456.00K | 1.15M | 1.87M |
| CommonStockEquity | -15.49M | -88.98M | -76.28M |
| TotalCapitalization | -15.49M | -88.98M | -76.28M |
| TotalEquityGrossMinorityInterest | -14.95M | -88.44M | -75.73M |
| MinorityInterest | 549.00K | 549.00K | 549.00K |
| StockholdersEquity | -15.49M | -88.98M | -76.28M |
| TreasuryStock | 0.00 | 33.00K | 33.00K |
| RetainedEarnings | -116.10M | -108.87M | -93.86M |
| AdditionalPaidInCapital | 100.60M | 19.92M | 17.61M |
| CapitalStock | 5.00K | 2.00K | 9.00K |
| CommonStock | 5.00K | 2.00K | 9.00K |
| TotalLiabilitiesNetMinorityInterest | 19.61M | 91.79M | 87.59M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 76.05M | 76.72M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 75.60M | 75.60M |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 455.00K | 1.12M |
| LongTermCapitalLeaseObligation | 0.00 | 455.00K | 1.12M |
| CurrentLiabilities | 19.61M | 15.74M | 10.87M |
| OtherCurrentLiabilities | 80.00K | ||
| CurrentDeferredLiabilities | 0.00 | 64.00K | |
| CurrentDeferredRevenue | 0.00 | 64.00K | |
| CurrentDebtAndCapitalLeaseObligation | 3.33M | 2.44M | 755.00K |
| CurrentCapitalLeaseObligation | 456.00K | 697.00K | 755.00K |
| CurrentDebt | 2.87M | 1.74M | |
| OtherCurrentBorrowings | 2.73M | ||
| CurrentNotesPayable | 147.00K | 1.74M | 0.00 |
| PayablesAndAccruedExpenses | 16.20M | 13.30M | 10.05M |
| CurrentAccruedExpenses | 7.50M | 5.38M | 1.90M |
| InterestPayable | 267.00K | ||
| Payables | 8.70M | 7.92M | 8.15M |
| TotalTaxPayable | 4.77M | 0.00 | |
| IncomeTaxPayable | 366.00K | 0.00 | |
| AccountsPayable | 3.94M | 7.92M | 8.15M |
| TotalAssets | 4.66M | 3.35M | 11.85M |
| TotalNonCurrentAssets | 885.00K | 1.32M | 2.21M |
| OtherNonCurrentAssets | 138.00K | 137.00K | |
| NonCurrentPrepaidAssets | 66.00K | 66.00K | 66.00K |
| NonCurrentNoteReceivables | 0.00 | 4.00K | |
| FinancialAssets | 188.00K | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 176.00K | 186.00K | 196.00K |
| OtherIntangibleAssets | 176.00K | 186.00K | 196.00K |
| NetPPE | 455.00K | 1.07M | 1.80M |
| AccumulatedDepreciation | -2.66M | -2.59M | -2.32M |
| GrossPPE | 3.11M | 3.66M | 4.12M |
| Leases | 788.00K | 788.00K | 788.00K |
| OtherProperties | 2.25M | 2.80M | 3.27M |
| MachineryFurnitureEquipment | 68.00K | 68.00K | 68.00K |
| Properties | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 3.78M | 2.04M | 9.65M |
| OtherCurrentAssets | 306.00K | 208.00K | 292.00K |
| HedgingAssetsCurrent | 155.00K | 0.00 | |
| CurrentDeferredAssets | 0.00 | 878.00K | 0.00 |
| RestrictedCash | 142.00K | 138.00K | |
| Receivables | 323.00K | 88.00K | 2.03M |
| AccountsReceivable | 323.00K | 88.00K | 2.03M |
| CashCashEquivalentsAndShortTermInvestments | 2.85M | 723.00K | 7.33M |
| CashAndCashEquivalents | 2.85M | 723.00K | 7.33M |
| CashFinancial | 2.85M | 723.00K | 7.33M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
| FreeCashFlow | -9.03M | -7.45M | -9.02M |
| RepaymentOfDebt | -5.75M | -222.00K | -207.00K |
| IssuanceOfDebt | 8.64M | 1.44M | 0.00 |
| IssuanceOfCapitalStock | 10.36M | 0.00 | 9.99M |
| CapitalExpenditure | -48.00K | -65.00K | |
| InterestPaidSupplementalData | 1.00K | 16.00K | 30.00K |
| EndCashPosition | 2.99M | 861.00K | 7.46M |
| BeginningCashPosition | 861.00K | 7.46M | 6.70M |
| ChangesInCash | 2.13M | -6.60M | 767.00K |
| FinancingCashFlow | 11.16M | 849.00K | 9.78M |
| CashFlowFromContinuingFinancingActivities | 11.16M | 849.00K | 9.78M |
| NetOtherFinancingCharges | -952.00K | -371.00K | |
| ProceedsFromStockOptionExercised | -1.13M | 0.00 | |
| NetPreferredStockIssuance | 0.00 | 9.99M | |
| PreferredStockIssuance | 0.00 | 9.99M | |
| NetCommonStockIssuance | 10.36M | 0.00 | |
| CommonStockIssuance | 10.36M | 0.00 | |
| NetIssuancePaymentsOfDebt | 2.89M | 1.22M | -207.00K |
| NetShortTermDebtIssuance | 2.90M | 1.44M | 0.00 |
| ShortTermDebtPayments | -5.74M | 0.00 | |
| ShortTermDebtIssuance | 8.64M | 1.44M | 0.00 |
| NetLongTermDebtIssuance | -17.00K | -222.00K | -207.00K |
| LongTermDebtPayments | -17.00K | -222.00K | -207.00K |
| InvestingCashFlow | 0.00 | -48.00K | -65.00K |
| CashFlowFromContinuingInvestingActivities | 0.00 | -48.00K | -65.00K |
| NetIntangiblesPurchaseAndSale | 0.00 | -65.00K | |
| PurchaseOfIntangibles | 0.00 | -65.00K | |
| NetPPEPurchaseAndSale | 0.00 | -48.00K | 0.00 |
| PurchaseOfPPE | 0.00 | -48.00K | 0.00 |
| OperatingCashFlow | -9.03M | -7.40M | -8.95M |
| CashFlowFromContinuingOperatingActivities | -9.03M | -7.40M | -8.95M |
| ChangeInWorkingCapital | -1.32M | 1.21M | 3.39M |
| ChangeInOtherWorkingCapital | -64.00K | 64.00K | |
| ChangeInOtherCurrentLiabilities | -566.00K | -500.00K | -440.00K |
| ChangeInPayablesAndAccruedExpense | -420.00K | -259.00K | 5.79M |
| ChangeInAccruedExpense | 383.00K | 484.00K | -454.00K |
| ChangeInPayable | -803.00K | -743.00K | 6.24M |
| ChangeInAccountPayable | -860.00K | -743.00K | 6.24M |
| ChangeInTaxPayable | 57.00K | 0.00 | |
| ChangeInIncomeTaxPayable | 57.00K | 0.00 | |
| ChangeInPrepaidAssets | -98.00K | 84.00K | -35.00K |
| ChangeInReceivables | -235.00K | 1.95M | -1.99M |
| ChangesInAccountReceivables | -235.00K | 1.94M | -1.99M |
| OtherNonCashItems | -3.21M | ||
| StockBasedCompensation | 1.93M | 2.31M | 4.02M |
| DepreciationAmortizationDepletion | 622.00K | 792.00K | 856.00K |
| DepreciationAndAmortization | 622.00K | 792.00K | 856.00K |
| Depreciation | 622.00K | 792.00K | 856.00K |
| OperatingGainsLosses | 177.00K | ||
| GainLossOnInvestmentSecurities | 350.00K | ||
| NetIncomeFromContinuingOperations | -7.23M | -11.71M | -17.21M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ABP
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|